← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2015Last known activity
Dec 27, 2025
Timeline
2010s
- Jun 1, 2013
Zai Lab Pty. Ltd.— Founded
Drugs by trial phase (40 distinct, 40 trials)
Phase 3 (22 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Eczema
- Gastrointestinal Stromal Tumors
- Hypersensitivity
- Idiopathic Pulmonary Fibrosis
- Liver Neoplasms
- Lung Diseases, Obstructive
- Lung Neoplasms
- Melanoma
- Ovarian Neoplasms
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Fibrosis
- Small Cell Lung Carcinoma
- Stomach Neoplasms
Recent trials (46)
- NCT07211776Lead sponsorPhase 3Dec 27, 2025
- NCT07235384Lead sponsorPhase 1Dec 4, 2025
- NCT07218146CollaboratorPhase 3Nov 30, 2025
- NCT07218146Lead sponsorPhase 3Nov 30, 2025
- NCT06885281Lead sponsorPhase 1/Phase 2May 12, 2025
- NCT06885281CollaboratorPhase 1/Phase 2May 12, 2025
- NCT06380907Lead sponsorPhase 2May 22, 2024
- NCT06380907CollaboratorPhase 2May 22, 2024
- NCT06462326Lead sponsorPhase 1Apr 16, 2024
- NCT06179069Lead sponsorPhase 1Jan 31, 2024
- NCT06179069CollaboratorPhase 1Jan 31, 2024
- NCT06140836CollaboratorPhase 3Jan 15, 2024
- NCT06162286Lead sponsorPhase 3Nov 17, 2023
- NCT05859464Lead sponsorPhase 1Jul 24, 2023
- NCT05859464CollaboratorPhase 1Jul 24, 2023
Details
- Founded
- Shanghai, CN Jun 1, 2013
- Last known activity
- Dec 27, 2025